1. NKP46 EXPRESSION IS A DIAGNOSTIC AND PROGNOSTIC BIOMARKER IN PRIMARY GASTROINTESTINAL T‐CELL LYMPHOPROLIFERATIONS. A CELAC NETWORK STUDY. (June 2017) Authors: Cheminant, M.; Bruneau, J.; Malamut, G.; Sibon, D.; Guegan, N.; Trinquand, A.; Lhermitte, L.; Brousse, N.; Suarez, F.; Frenzel, L.; Delarue, R.; Marçais, A.; Macintyre, E.; Asnafi, V.; Lhospice, F.; Bonnafous, C.; Molina, T.; Meresse, B.; Cellier, C.; Cerf‐Bensussan, N. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 44 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. OBINUTUZUMAB PLUS DHAP FOLLOWED BY AUTOLOGOUS STEM CELL TRANSPLANTATION (ASCT) PLUS OBINUTUZUMAB MAINTENANCE PROVIDES A HIGH MRD RESPONSE RATE IN UNTREATED MCL PATIENTS. RESULTS OF LYMA‐101 TRIAL, A LYSA GROUP STUDY. (12th June 2019) Authors: Le Gouill, S.; Beldi‐Ferchiou, A.; Cacheux, V.; Salles, G.; Canioni, D.; Bodet‐Milin, C.; Alcantara, M.; Delwail, V.; Gastinne, T.; Thieblemont, C.; Maisonneuve, H.; Lamy de la Chapelle, T.; Oberic, l.; Bouabdallah, K.; Ribrag, V.; Delfau‐Larue, M.; Macintyre, E.; Hermine, O. Journal: Hematological oncology Issue: Volume 37(2019)Supplement 2 Page Start: 44 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. PREDICTION OF RELAPSE BY STANDARDIZED IG‐BASED ALLEL‐SPECIFIC QPCR, DDPCR AND AMPLICON NGS FOR MRD MONITORING IN MANTLE CELL LYMPHOMA: A COMPARATIVE ANALYSIS BY THE EU‐MCL NETWORK. (17th June 2021) Authors: Pott, C.; Macintyre, E.; Delfau, M.‐H.; Weiß, A.; Schilhabel, A.; Soehlbrand, A.; Kehden, B.; Darzentas, N.; Kotrova, M.; Schoen, F.; Ribrag, V.; Brueggemann, M.; Villarese, P.; Dreyling, M.; Hermine, O.; Kluin‐Nelemans, H.; Jiang, L.; Hoster, E. Journal: Hematological oncology Issue: Volume 39(2021)Supplement 2 Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗